Serum DLK1 is a potential prognostic biomarker in patients with hepatocellular carcinoma.
about
The essential role of MTDH in the progression of HCC: a study with immunohistochemistry, TCGA, meta-analysis and in vitro investigation.Supplements of vitamins B9 and B12 affect hepatic and mammary gland gene expression profiles in lactating dairy cowsTargeting endogenous DLK1 exerts antitumor effect on hepatocellular carcinoma through initiating cell differentiationRole of superoxide dismutase in hepatitis B virus-related hepatocellular carcinomaPaternally Inherited DLK1 Deletion Associated With Familial Central Precocious Puberty.The Recent Advances on Liver Cancer Stem Cells: Biomarkers, Separation, and Therapy.Clinical outcome of hepatocellular carcinoma can be predicted by the expression of hepatic progenitor cell markers and serum tumour markers.
P2860
Q33623086-7026FEBD-590C-41D9-BA03-8E178CFEFBDFQ36104321-A23703A9-096D-4C38-8FB6-D5F0DA990511Q37687639-66F73536-D4A0-4C16-9CB6-B611E3ED4C1EQ40348837-653808D4-2D4B-4FEA-92D9-A926A4A7C409Q47821601-E3B2724E-C123-4BAA-9D60-986C3E40DD4CQ53106095-E0BAD8F8-D1BA-4E79-AF02-038B5D59FD31Q55227617-A83A2A18-A0F7-4731-8F97-022063269BBD
P2860
Serum DLK1 is a potential prognostic biomarker in patients with hepatocellular carcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Serum DLK1 is a potential prognostic biomarker in patients with hepatocellular carcinoma.
@en
type
label
Serum DLK1 is a potential prognostic biomarker in patients with hepatocellular carcinoma.
@en
prefLabel
Serum DLK1 is a potential prognostic biomarker in patients with hepatocellular carcinoma.
@en
P2093
P2860
P1433
P1476
Serum DLK1 is a potential prognostic biomarker in patients with hepatocellular carcinoma.
@en
P2093
Fu-hua Chen
Hai-yang Xie
Jin-jun Li
Mei-ling Cui
Tao-yang Chen
P2860
P2888
P304
P356
10.1007/S13277-015-3607-8
P577
2015-05-28T00:00:00Z
P6179
1028596103